Masmudur M. Rahman

1.7k total citations
40 papers, 970 citations indexed

About

Masmudur M. Rahman is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Masmudur M. Rahman has authored 40 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 15 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Masmudur M. Rahman's work include Virus-based gene therapy research (27 papers), Herpesvirus Infections and Treatments (11 papers) and CAR-T cell therapy research (10 papers). Masmudur M. Rahman is often cited by papers focused on Virus-based gene therapy research (27 papers), Herpesvirus Infections and Treatments (11 papers) and CAR-T cell therapy research (10 papers). Masmudur M. Rahman collaborates with scholars based in United States, Canada and Poland. Masmudur M. Rahman's co-authors include Grant McFadden, Francis Ka-Ming Chan, Himani Nailwal, Eugénie Bagdassarian, Mohamed A. M. Ali, Sonia Wennier, Jia Liu, Shoudong Li, Sunao Takeshita and Kyoji Ikeda and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Immunity.

In The Last Decade

Masmudur M. Rahman

38 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masmudur M. Rahman United States 17 421 385 345 289 169 40 970
Louisa S. Chard United Kingdom 21 714 1.7× 532 1.4× 508 1.5× 258 0.9× 187 1.1× 39 1.5k
Carole Evelegh Canada 21 777 1.8× 793 2.1× 418 1.2× 309 1.1× 186 1.1× 28 1.4k
Eugene Kang United States 14 522 1.2× 568 1.5× 382 1.1× 369 1.3× 315 1.9× 15 1.4k
Karim Essani United States 17 305 0.7× 411 1.1× 173 0.5× 341 1.2× 317 1.9× 49 1.0k
Francesca Avogadri United States 15 462 1.1× 284 0.7× 542 1.6× 1.2k 4.3× 150 0.9× 21 2.0k
Jiangao Zhu United States 11 385 0.9× 485 1.3× 193 0.6× 555 1.9× 213 1.3× 18 1.1k
Kevin A. Cassady United States 23 557 1.3× 887 2.3× 695 2.0× 408 1.4× 661 3.9× 59 1.6k
Javier Hernández France 26 668 1.6× 182 0.5× 470 1.4× 1.2k 4.0× 176 1.0× 49 2.0k
Cagan Gurer United States 12 382 0.9× 200 0.5× 330 1.0× 574 2.0× 235 1.4× 16 1.2k
Elena Y. Dobrikova United States 24 708 1.7× 422 1.1× 384 1.1× 310 1.1× 122 0.7× 45 1.5k

Countries citing papers authored by Masmudur M. Rahman

Since Specialization
Citations

This map shows the geographic impact of Masmudur M. Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masmudur M. Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masmudur M. Rahman more than expected).

Fields of papers citing papers by Masmudur M. Rahman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masmudur M. Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masmudur M. Rahman. The network helps show where Masmudur M. Rahman may publish in the future.

Co-authorship network of co-authors of Masmudur M. Rahman

This figure shows the co-authorship network connecting the top 25 collaborators of Masmudur M. Rahman. A scholar is included among the top collaborators of Masmudur M. Rahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masmudur M. Rahman. Masmudur M. Rahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahman, Masmudur M., Honor L. Glenn, Karen V. Kibler, et al.. (2025). Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication. Viruses. 17(2). 284–284.
2.
Jazowiecka-Rakus, Joanna, et al.. (2024). Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma. International Journal of Molecular Sciences. 25(20). 11225–11225. 2 indexed citations
3.
Glenn, Honor L., et al.. (2024). Individual herpes simplex virus 1 (HSV-1) particles exit by exocytosis and accumulate at preferential egress sites. Journal of Virology. 98(2). e0178523–e0178523. 2 indexed citations
4.
Rahman, Masmudur M., et al.. (2023). Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer. Cancer Research Communications. 3(6). 952–968. 3 indexed citations
5.
Rahman, Masmudur M., et al.. (2023). Tumor Tropism of DNA Viruses for Oncolytic Virotherapy. Viruses. 15(11). 2262–2262. 9 indexed citations
6.
7.
8.
Christie, John D., Nicole Appel, Liqiang Zhang, et al.. (2022). Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma. Cancers. 14(2). 337–337. 8 indexed citations
9.
Villa, Nancy, Masmudur M. Rahman, Meaghen E. Sharik, et al.. (2022). Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma. Oncotarget. 13(1). 490–504. 4 indexed citations
10.
Jazowiecka-Rakus, Joanna, Masmudur M. Rahman, Grant McFadden, et al.. (2021). Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma. Cancers. 13(6). 1394–1394. 17 indexed citations
11.
Neves, Fabiana, Grant McFadden, Bertram L. Jacobs, et al.. (2021). Convergent Loss of the Necroptosis Pathway in Disparate Mammalian Lineages Shapes Viruses Countermeasures. Frontiers in Immunology. 12. 747737–747737. 20 indexed citations
12.
Rahman, Masmudur M., et al.. (2021). RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells. Journal of Virology. 95(14). e0015121–e0015121. 8 indexed citations
13.
Nailwal, Himani, et al.. (2021). A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation. Immunity. 54(2). 247–258.e7. 74 indexed citations
14.
Woo, Yanghee, Susanne G. Warner, Rula C. Geha, et al.. (2021). The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase. Clinical Medicine Insights Oncology. 15. 4 indexed citations
15.
Villa, Nancy, Masmudur M. Rahman, Jacquelyn Kilbourne, et al.. (2020). Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma. Molecular Therapy — Oncolytics. 18. 171–188. 11 indexed citations
16.
Kellish, Patrick, Masmudur M. Rahman, Akbar Nawab, et al.. (2019). Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival. Journal of Clinical Investigation. 129(6). 2279–2292. 40 indexed citations
17.
Phelps, Michael, et al.. (2018). Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma. Molecular Therapy — Oncolytics. 11. 52–61. 27 indexed citations
18.
Rahman, Masmudur M. & Grant McFadden. (2017). Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN‐Induced Antiviral State in a Highly Species‐Specific Fashion. Viruses. 9(2). 27–27. 10 indexed citations
19.
Rahman, Masmudur M., Sunao Takeshita, Kazuhiko Matsuoka, et al.. (2015). Proliferation-coupled osteoclast differentiation by RANKL: Cell density as a determinant of osteoclast formation. Bone. 81. 392–399. 33 indexed citations
20.
Acharya, Asha, et al.. (2002). Bombyx mori nucleopolyhedrovirus: Molecular biology and biotechnological applications for large-scale synthesis of recombinant proteins. Current Science. 83(4). 455–465. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louisa S. Chard Breakdown of academic impact, for papers by Carole Evelegh Breakdown of academic impact, for papers by Eugene Kang Breakdown of academic impact, for papers by Karim Essani Breakdown of academic impact, for papers by Francesca Avogadri Breakdown of academic impact, for papers by Jiangao Zhu Breakdown of academic impact, for papers by Kevin A. Cassady Breakdown of academic impact, for papers by Javier Hernández Breakdown of academic impact, for papers by Cagan Gurer Breakdown of academic impact, for papers by Elena Y. Dobrikova
Rankless by CCL
2026